The goal of this clinical trial is to learn if platelet rich plasma works to treat early stage trigger finger in adults. It will also learn about the safety platelet rich plasma. The main questions it aims to answer are: Does platelet rich plasma lower the pain associated with trigger finger of participants? Does it improve the hand grip strength and Q DASH score of participants? Researchers will compare platelet rich plasma to Depo-Medrol steroid (a known standard of care for early stage trigger finger) to see if platelet rich plasma works to treat early trigger finger. Participants will: Take platelet rich plasma or a depo-medrol steroid intralesional injection at recruitment into the intervention Visit the clinic once every 4 weeks for checkups and parameter measurements. Investigator will will keep a record of participants progress in symptom remission
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
40
Freshly prepared autologus platelet rich plasma
Methylprednisolone acetate 20mg/ml injection
symptom resolution post injection
reduction of pain using VAS and absence snapping of finger
Time frame: 3 months
Hand grip strength
measured grip using hand dynamomter
Time frame: 3 month
Q- DASH score
11-item self reported disability questionnaire that consider upper extremity as one functional unit
Time frame: 3month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.